Healthcare -
Biotechnology - NASDAQ - US
$ 0.7817
0.786 %
$ 42.6 M
Market Cap
9.77
P/E
SPRO - OPERATING INCOME
Operating Income SPRO - Spero Therapeutics, Inc.
21.5 M
LAST VALUE
49.81%
2 YEAR CAGR
20.13%
5 YEAR CAGR
0.00%
10 YEAR CAGR